Overview

A Study to Evaluate the Safety, Pharmacokinetics and Oral Bio Availability of Veliparib in Subjects With Solid Tumors

Status:
Completed
Trial end date:
2017-06-29
Target enrollment:
Participant gender:
Summary
This is a 3 part phase 1 study to evaluate the safety, pharmacokinetic and oral bioavailability of veliparib in subjects with solid tumors.
Phase:
Phase 1
Details
Lead Sponsor:
AbbVie
Treatments:
Veliparib